Who has invested in Ascend?

Abingworth, Petrichor, DCVC Bio, 4BIO Capital, Cathay Health, Deerfield Management are named among the investors backing Ascend.

Ascend Funding: $130M Raised, Series A (2023)

Ascend funding overview

Ascend is based in San Francisco, CA. Ascend has raised $130M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2023. The round record for Ascend runs through 2023; nothing later has been disclosed. Investors on record include Abingworth, Petrichor, DCVC Bio, 4BIO Capital, Cathay Health, Deerfield Management and 3 others. 9 distinct backers are named across the disclosed rounds.

Ascend at a glance

Total raised: $130M
Latest round: Series A
Latest round date: January 2023
Headquarters: San Francisco, CA
Notable investors: Abingworth, Petrichor, DCVC Bio, 4BIO Capital, Cathay Health, Deerfield Management, Digitalis Ventures, Ajinomoto Co., Inc.

Frequently asked about Ascend funding

How much has Ascend raised?: Ascend has raised $130M in total disclosed funding across the rounds on record.
Who has invested in Ascend?: Abingworth, Petrichor, DCVC Bio, 4BIO Capital, Cathay Health, Deerfield Management are named among the investors backing Ascend.
What was the latest Ascend funding round?: The most recent disclosed round is a Series A, announced in January 2023.
Where is Ascend based?: Ascend is based in San Francisco, CA.
When did Ascend last raise?: The last disclosed Ascend round closed in January 2023 at Series A.

Totals shown for Ascend aggregate every disclosed round on file. To see how that compares, browse the companies in San Francisco and the investors behind them below.

Ascend Funding: $130M Raised, Series A (2023)

Ascend funding overview

Ascend at a glance

Frequently asked about Ascend funding

Companies related to Ascend (35)

Browse related funding lists (9)